News

Astronauts aboard the ISS resumed critical research on brain circulation, cancer cell behaviour, and space biotechnology. The ...
Knoxville lawyer Jeff Hagood has been nominated to the Tennessee Valley Authority Board of Directors by President Donald ...
Scientists from UCSD’s Sanford Stem Cell Institute are working in collaboration with Axiom Space and the JM Foundation on the ...
Ford CEO calls Lidar 'mission critical' to self-driving, Tesla Q2 delivery numbers due out, and feds propose slashing EV tax ...
In soil remediation processes, the mediating role of microorganisms in soil nutrient cycling is critical. The decline in ...
Rising concern about environmental pollution due to traditional plastic packaging and growing demand for food safety have promoted the emergence of ...
Telitacicept is approved in China for systemic lupus erythematosus (SLE), rheumatoid arthritis (RA), and generalized myasthenia gravis (gMG). A global Phase 3 clinical trial in gMG is currently ...
NS-33 will be Blue Origin's 13th crewed launch to date, and the fifth New Shepard launch of 2025. The mission will carry six ...
“I’m truly delighted to join the Board of Directors at Ability Biotherapeutics,” said Dr. Maki. “Ability’s bold mission to revolutionize targeted antibody therapies for cancer and autoimmune diseases, ...
[email protected] Media contact: DJ Webster [email protected] The articles, information, and content displayed on this webpage may include materials prepared and provided by third parties.
Vor Bio, a clinical-stage cell and genome engineering company, has appointed Mr. Erez Kalir to its Board of Directors, creating a new seat following a recent private investment in public equity ...